Taylor John Clayton 4
4 · Aceragen, Inc. · Filed Jan 19, 2023
Insider Transaction Report
Form 4
Aceragen, Inc.ACGN
Taylor John Clayton
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Series Z Convertible Preferred Stock
2023-01-17−22,810→ 0 total→ Common Stock (1,341,764 underlying) - Exercise/Conversion
Common Stock
2023-01-17+1,341,764→ 1,469,482 total
Footnotes (2)
- [F1]On January 17, 2023, the Issuer's Series Z Non-Voting Convertible Preferred Stock, par value $0.01 per share ("Series Z Preferred Stock") converted into shares of common stock of the Issuer, par value $0.001 per share ("Common Stock"). By operation of the certificate of designation for the Series Z Preferred Stock, each share of Series Z Preferred Stock was converted into 1,000 shares of Common Stock for no consideration.
- [F2]Reflects a 1-for-17 reverse stock split, which became effective on January 17, 2023 at 4:59 pm Eastern Time.